Looming EU GDPR Requirements: What Life Sciences Companies Must Do to Ensure Compliance

Thursday, May 10, 2018

12:00–2:00 pm ET


Taking effect on May 25, the European Union's General Data Protection Regulation (GDPR) is a significant change to the EU's current data protection regime, with regulators poised to impose much heavier fines for noncompliance—in the most serious cases as high as €20m or four percent of worldwide turnover.

Many US life sciences companies, even those without a European presence, will be directly affected and need to take steps in very short order to comply with GDPR requirements applicable to many aspects of their business.

Hosted by Arnold & Porter's European Data Privacy team, this webinar details how life will differ under GDPR; the new legislation's impact on your business (even if you have no presence in the EU); the key issues that in-house lawyers, compliance officers, HR professionals, and other stakeholders should know; and the practical steps that life sciences businesses can take now to adhere to the new regulation.


  • Overview of the GDPR: what it covers and how it applies to life sciences companies
  • Update on the latest guidance and other developments in the run-up to implementation
  • Key considerations for US life sciences companies:
      • Operating clinical trials in the EU
      • Using health data from EU patients
      • Engaging with healthcare professionals in the EU
      • Marketing to, and engaging with, EU patients
      • Processing European employee data in line with GDPR
      • Incorporating discovery/disclosure of EU personal data in US legal proceedings
      • Interacting with EU life sciences regulatory regime
  • Other hot topics and open issues

Email Disclaimer